We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Astellas to Pay $98M to Settle Prograf Antitrust Case
Astellas to Pay $98M to Settle Prograf Antitrust Case
Astellas Pharma will pay $98 million to settle a class action lawsuit that accuses the brandmaker of filing a frivolous citizen petition and subsequent lawsuit solely to delay generic competition to its transplant drug Prograf.